Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Beverage brands update Dry January marketing based on changing consumer habits
Today, people generally seek balance when pursuing their personalized wellness goals in a new year.
Future of Marketing Briefing: X claims an ad comeback, reality proves out a different thesis
The comeback story X wants told, and the ad business it actually has.
Mythbuster: What AI is not about to do in advertising
As the hype around AI thins into something closer to reality, the ad industry is quietly drawing a line around what LLMs can do — and what they will not be trusted to touch.